铝镁加混悬液联合奥美拉唑治疗胃溃疡合并胃出血的临床分析

Abstract
Figure/Table
References (16)
Related Citation (9)

Download: PDF (0 KB) HTML (33 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the clinical effect of Almagate Suspension combined with Omeprazole in the treatment of gastric ulcer complicated with gastric hemorrhage.Methods The clinical data of 120 patients with gastric ulcer and gastric hemorrhage treated in our hospital from February 2014 to March 2017 were analyzed.According to the different therapeutic methods,they were evenly divided into control group(intravenous drip of Omeprazole)and observation group (on the basis of Omeprazole,Almagate Suspension was combined).The improvement of clinical symptoms,clinical effect,and the incidence of adverse reactions in the two groups were observed.Results In the observation group,time to stop blood vomiting,time of stool OB test negative,andabdominal pain disappearing were(1.6±0.3)d,(4.5±1.0)d,and(2.1±0.3)d,all shorter than those in the control group[(2.2±0.5),(6.7±1.2)d,and(3.5±0.6)d]in turn.The total effective rate of clinical treatment was 96.7%,much higher than that in the control group accounting for 80.0%.The percentage of adverse reactions including nausea and vomiting,rash，and abdominal discomfort was 3.3%,0.0%,and 3.3%,all lower than those in the control group(10%,8.3%,and 8.3%)accordingly,which were displayed statistical differences(P<0.05).Conclusion Combination of Almagate Suspension and Omeprazole in the treatment of gastric ulcer complicated with gastric hemorrhage has advantages of remarkable improvement of clinical symptoms，great effect,and few adverse reactions,which is worthy of promotion in clinic.

Key words： Almagate Suspension Omeprazole Gastriculcer Gastric hemorrhage

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHANG Qing-li
	SUN Da-yong
	LING Tao
	ZHENG Yan-e
	ZENG Xiao-hui

Cite this article:

ZHANG Qing-li,SUN Da-yong,LING Tao, et al. Clinical analysis of Almagate Suspension combined with Omeprazole in the treatment of gastric ulcer complicated with gastric hemorrhage[J]. 中国当代医药, 2017, 24(27): 61-63.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2017/V24/I27/61

[1]	黄文瑜.奥美拉唑联合铝碳酸镁治疗胃溃疡合并胃出血的效果观察[J].中国当代医药，2014，21（24）：115-117.
[2]	徐冬梅.铝碳酸镁联合奥美拉唑治疗胃溃疡合并胃出血的疗效观察[J].中西医结合心血管病杂志电子杂志，2016，4（28）：181-182.
[3]	冯莉.奥美拉唑联合铝碳酸镁治疗胃溃疡合并胃出血效果观察[J].中国当代医药，2013，20（2）：78-79.
[4]	许秀燕.46例胃溃疡患者采用铝碳酸镁咀嚼片联合奥美拉唑治疗的临床效果观察[J].中国中西医结合消化杂志，2014，22（6）：339-340.
[5]	林根友，肖兆群，陆维宏.中西医结合补救治疗幽门螺杆菌感染的临床研究[J].中国现代医生，2013，51（18）：93-96.
[6]	张文峰，曹勇，王文峰.奥美拉唑联合铝碳酸镁治疗胃溃疡合并胃出血的临床效果观察[J].泰山医学院学报，2014，35（11）：1146-1147.
[7]	李如职，麦佐镰，邓经斌，等.凝血酶联合奥美拉唑治疗残胃出血的效果[J].广东医学，2014，35（5）：3567-3568.
[8]	邹彦，应岩富，林才毓.铝碳酸镁联合奥美拉唑对胃溃疡合并胃出血的疗效分析[J].中国药师，2015，18（4）：611-613.
[9]	Sugimoto M，Yamaoka Y，Furuta T．Influence of interleukin polymorphisms on development of gastric cancer and peptic ulcer[J].World J Gastroenterol，2010，16（10）：1188-1200.
[10]	李瑞宝.铝碳酸镁联合奥美拉唑对胃溃疡合并胃出血的疗效分析[J].中国医药科学，2015，5（10）：35-37.
[11]	Tsuji Y，Ohata K，Ito I，et al.Risk factors for bleeding after endoscopic submucosal dissection for gastric lesions[J].World J Gastroenterol，2010，16（23）：2913-2917.
[12]	吕志芳.凝血酶加奥美拉唑治疗残胃出血的临床疗效分析[J].转化医学电子杂志，2015，2（9）：79-80.
[13]	康勤洪.凝血酶加奥美拉唑治疗残胃出血的临床有效性与安全性综合评价[J].现代消化及介入诊疗，2015，20（5）：535-536.
[16]	邹燕平，陈荷花，洪卫国.奥美拉唑治疗胃溃疡合并出血132 例疗效分析[J].中国医学创新，2013，10（36）：118-120.
[14]	Park MJ，Choi SH，Kim D，et al.Association between Helicobacter pylori seropositivity and the coronary artery calcium score in a screening population[J].Gut Liver，2011，5（3）：321-327.
[15]	Goldstein JL，Huang B，Amer F，et al.Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin：results of a post HOC subanalysis[J].Clin Ther，2004，26（10）：1637-1643.